within Pharmacolibrary.Drugs.ATC.A;

model A07BC05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 3000 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Diosmectite is a natural silicate clay used as an adsorbent antidiarrheal agent. It acts by coating the gastrointestinal mucosa and binding toxins and bacteria, reducing their interaction with the gut lining. It is primarily used for the symptomatic treatment of acute and chronic diarrhea in children and adults. Diosmectite is available in many countries as an over-the-counter medicine.</p><h4>Pharmacokinetics</h4><p>No systemically relevant pharmacokinetic parameters are typically reported for diosmectite, as it is not absorbed from the gastrointestinal tract in humans. All relevant pharmacokinetic models assume no systemic absorption.</p><h4>References</h4><ol><li><p>Dupont, C, et al., &amp; Plique, O (1992). Effect of diosmectite on intestinal permeability changes in acute diarrhea: a double-blind placebo-controlled trial. <i>Journal of pediatric gastroenterology and nutrition</i> 14(4) 413–419. DOI:<a href=&quot;https://doi.org/10.1097/00005176-199205000-00007&quot;>10.1097/00005176-199205000-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1517944/&quot;>https://pubmed.ncbi.nlm.nih.gov/1517944</a></p></li><li><p>Theodorou, V, et al., &amp; Buéno, L (1994). Protective action of diosmectite treatment on digestive disturbances induced by intestinal anaphylaxis in the guinea-pig. <i>Alimentary pharmacology &amp; therapeutics</i> 8(3) 295–299. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2036.1994.tb00291.x&quot;>10.1111/j.1365-2036.1994.tb00291.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7918924/&quot;>https://pubmed.ncbi.nlm.nih.gov/7918924</a></p></li><li><p>Yuan, Q, et al., &amp; Boyd, SA (2021). Natural organic matter does not diminish the mammalian bioavailability of 2,3,7,8-tetrachlorodibenzo-p-dioxin. <i>Chemosphere</i> 264(Pt 1) 128420–None. DOI:<a href=&quot;https://doi.org/10.1016/j.chemosphere.2020.128420&quot;>10.1016/j.chemosphere.2020.128420</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33032214/&quot;>https://pubmed.ncbi.nlm.nih.gov/33032214</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A07BC05;
